Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

ChristianaCare

Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

Cancer Research at the
Helen F. Graham Cancer Center
& Research Institute

Oncology Patient Advocates for Clinical Trials (OPACT)

Oncology Patient Advocates for Clinical Trials (OPACT) is a group of cancer survivors who have participated in clinical trials and seek to help other patients who may be considering clinical trials. We build bridges between patients, physicians, nurses, social workers and others who provide care to cancer patients considering participation in a Helen F. Graham Cancer Center & Research Institute clinical trial.

Mission & Vision

Our goal is to create awareness of the opportunities patients have in the clinical trial program. We will serve as a resource for both new patients considering clinical trials, and clinical trial practitioners to improve the the overall experience for the patient. We will communicate the trial results to patients once available and also celebrate our patients’ accomplishments through an annual event.

What is a Clinical Trial?

A clinical trial is a research study designed to answer a specific scientific question. Research clinical trials are conducted with cancer patients to determine if a new treatment or therapy is effective. Treatments can include surgery, radiation therapy and chemotherapy, either alone or in combination.

Some clinical trials are designed to study ways to prevent cancer. They are called prevention trials. Other studies examine the psychological impact of cancer, ways to improve patient quality of life, and ways to control symptoms or side effects. A clinical trial is often referred to as a protocol.

The cancer clinical trials available through the Helen F. Graham Center & Research Institute are sponsored by the National Cancer Institute (NCI) and other national research partners. The ChristianaCare cancer research program is a NCI Community Oncology Research Program (NCORP). As a NCORP member, the Helen F. Graham Cancer Center & Research Institute provides patients with the newest cancer therapies, including more than 100 clinical trials sponsored by the federal government and drug companies for the prevention and treatment of cancer at different stages.

How We Can Help

We understand what you’re going through because we’ve been there. We know how overwhelming these decisions about treating your cancer can feel. The good news is that you have options. Clinical trials offer you access to new treatments that might otherwise be unavailable.

You also have us. We are your advocates. We can help ease the burden of making these decisions by sharing our knowledge and experience with clinical studies. We know that from a patient’s perspective the more information you have, the easier it will be for you and your family to make the decision that’s right for you.

To talk with one of us, call the cancer research office at 302-623-4450.

Cancer Research Program
Helen F. Graham Cancer Center & Research Institute
4701 Ogletown-Stanton Road, Suite 2200, Newark, DE 19713 directions
For more information, call 302-623-4450 or e-mail us.